Table 2 Data category by feedback measure and type of cancer

Category 1

Level of hospital

0 (0.0%)

0 (0.0%)

0 (0.0%)

1 (1.2%)

0 (0.0%)

1 (0.4%)

Population-based registry, routine-inpatient data

Surgery; guideline not reliant on clinical stage

0 (0.0%)

0 (0.0%)

0 (0.0%)

4 (4.8%)

3 (7.3%)

7 (2.9%)

Sub-total

0 (0.0%)

0 (0.0%)

0 (0.0%)

5 (6.0%)

3 (7.3%)

8 (3.3%)

Category 2

Initial diagnostic or staging procedures

0 (0.0%)

0 (0.0%)

2 (4.3%)

14 (16.9%

3 (7.3%)

19 (7.8%)

Core clinical registry

Initial treatment in relation to clinical stage-at-diagnosis or performance status or specific prognostic features of the cancer

15 (60.0%)

10 (21.3%)

23 48.9%))

23 (27.7%))

25 (61.0%)

96 (39.5%)

Participation in clinical trial

0 (0.0%)

0 (0.0%)

0 (0.0%)

2 (1.2%)

0 (0.0%)

2 (0.8%)

Assessment by multi-disciplinary team;

0 (0.0%)

0 (0.0%)

0 (0.0%)

2 (1.2%)

0 (0.0%)

2 (0.8%)

Sub-total

15 (60.0%)

10 (21.2%)

25 (53.2%)

41 (49.4%)

28 (68.3%)

119 (49.0%)

Category 3

Details of surgery;

0 (0.0%)

0 (0.0%)

10 (21.3%)

0 (0.0%)

0 (0.0%)

10 (4.1%)

Extended clinical registry medical record review,

Treatments for complications of cancer treatment

0 (0.0%)

3 (6.4%)

2 (4.3%)

1 (1.2%)

0 (0.0%)

6 (2.5%)

Long-term follow-up;

1 (4.0%)

3 (6.4%)

3 (6.4%)

2 (2.4%)

4 (9.8%)

13 (5.3%)

Management of disease progression including pain relief and palliation

2 (8.0%)

22 (46.8%)

6 (12.8%)

29 (34.9%)

0 (0.0%)

59 (24.3%)

Sub-total

3 (12.0%)

28 (59.6%)

21 (44.9%)

32 (38.6%)

4 (9.8%)

88 (36.1%)

Category 4

Communication and information sharing between clinician and patient

7 (28.0%)

9 (19.1%)

1 (2.1%)

5 (6.0%)

6 (14.6%)

28 (11.5%)

Patient interview, audio-taping of consultation

Grand total

25 (100%)

47 (100%)

47 (100%)

83 (100%)

41 (100%)

243 (100%)